OPINION
FERNANDEZ, Circuit Judge:
Leslie Abromson, Ronald Angelo, Louis Camardella, Eh Bailan, Elie de Comminges, and Sandra Kolker (collectively “Abromson”), acting on their own behalf and on behalf of a court-certified class and sub-class, appeal the district court’s judgment in favor of defendants American Pacific Corporation, Fred Gibson, Jr., C. Keith Rooker, David Keys, John R. Gibson, W. Carroll, Thomas War, Thomas Turner, Norval Pohl, and Victor Rosenzweig (collectively “AmPac”) in Abromson’s action against AmPac for securities fraud under 15 U.S.C. §§ 77k, 77o (Securities Act of 1933, as amended, §§ 11, 15) and 15 U.S.C. §§ 78j(b), 78t (Securities Exchange Act of 1934, as amended, §§ 10(b), 20) and 17 C.F.R. § 240.10b-5 (Rule 10b-5). Abromson alleged misrepresentations or omissions regarding AmPac’s relationship with Thiokol Corporation, its largest customer, and regarding the business prospects of the fire suppression agent Halotron. The district court certified a class of plaintiffs comprising any person who purchased AmPac stock between April 15, 1992 and June 11, 1993, the “class period,” and a sub-class of persons who purchased stock in AmPac’s public offering of April 15, 1992. The district court granted AmPac’s motion for summary judgment on the Thiokol claims and it granted summary judgment in favor of the outside directors of AmPac on all claims. After trial, a jury returned a verdict in favor of AmPac on the Halotron claims. The district court thereafter entered judgment for AmPac. Abromson appealed and AmPac cross appealed the district court’s denial of its motion for judgment as a matter of law on claims that went to the jury. We affirm.
BACKGROUND
On April 15, 1992, AmPac and certain selling shareholders issued shares in a public offering of its common stock. On that date, AmPac’s stock closed trading at a price of $31)4 per share. On June 11, 1993, AmPac’s stock closed trading at a price of $20)4 per share. Abromson brought suit against AmPac under §§ 77k, 77o, 78j(b), 78t, and Rule 10b-5, on the basis of alleged misstatements regarding AmPac’s relationship with Thiokol, the customer that provided the lion’s share of AmPac’s revenues (40%, 47%, and 63%, respectively, in the three years preceding 1991). Abromson alleged misrepresentations or omissions regarding AmPac’s agreement to supply Thiokol with ammonium perchlorate (AP), the oxidizing agent for solid-fuel rockets.
When an explosion destroyed one of the two AP manufacturing facilities in the United States, NASA became concerned because it wanted two sources for that substance. That led to a contract between AmPac’s subsidiary, Western Electrochemical Corporation [901]*901and Thiokol.1 AmPac agreed to build a new AP manufacturing facility and Thiokol advanced the funds with which to begin construction. AmPac also entered into a loan agreement with Security Pacific Bank Washington, N.A.,2 pursuant to which it obtained financing of $92 million for the facility. Thiokol agreed that during the seven year amortization period of the Security Pacific loan, it would place enough orders for AP to assure repayment of the loan. Moreover, Thiokol agreed to pay a surcharge on all AP orders during the amortization period of the loan in order to help defray the costs of constructing and financing the AP manufacturing facility. The agreements between Thiokol and AmPac were incorporated by reference into Thiokol’s contract with NASA.
Prior to and during the class period, AmPac made numerous declarations in which it stated that Thiokol was “obligated” to purchase AP during the seven-year period following the commencement of the agreements, that these sales were “assured,” and that the Thiokol contract would “insulate” AmPac from competition in the AP market. AmPac included those statements in its SEC filings, including AmPac’s annual 10-K reports for 1991 and 1992, as well as the prospectus for the April 15, 1992 stock offering.
At the same time, NASA wanted to shorten the seven-year amortization period for AmPac’s loan from Security Pacific, and AmPac was engaged in discussions about that with officials from NASA and Thiokol. In fact, AmPac’s 1991 10-K report indicates the possibility of paying off the Security Pacific loan in 1994, three years earlier than anticipated by the original agreement. However, the parties disagreed on the question of whether early repayment of the loan would terminate Thiokol’s obligation to purchase AP from AmPac. The parties did not reach an agreement on repayment, and they continued to disagree regarding the effect of any repayment upon Thiokol’s purchase obligations.
The public became aware of the disagreement on June 11, 1993, when Thiokol filed suit in Utah state court against AmPac and sought a judicial declaration that complete repayment of the Security Pacific loan would terminate Thiokol’s contractual obligation to purchase AP from AmPac. Thiokol alleged that AmPac had agreed to early repayment of the loan. That agreement simply did not exist, and there was no evidence that it did. Upon public disclosure of Thiokol’s lawsuit, the price of AmPae’s stock dropped precipitously. Abromson asserts that AmPac should have publicly disclosed the disagreement among it, NASA, and Thiokol regarding the contractual agreements and that the failure to do so violated the securities laws.
Abromson also faults AmPae’s disclosures with respect to Halotron, a fire suppression agent intended to replace Halón, a more widely used substance that may cause damage to the ozone layer. The district court denied AmPac’s request for summary judgment and the case went to trial on the Halo-tron claims. During his opening statement regarding them, AmPac’s attorney made reference to the absence of a Securities and Exchange Commission enforcement proceeding against the defendants. Abromson now argues that the remark was improper and that it requires reversal of the judgment. In addition, Abromson argues that the court’s failure to give one of her proposed instructions was an error requiring reversal. AmPac moved for judgment as a matter of law on the Halotron claims both at the close of Abromson’s case and at the close of all evidence. It now cross appeals the district court’s denial of those motions.
JURISDICTION AND STANDARD OF REVIEW
The district court had jurisdiction pursuant to 28 U.S.C. § 1331. We have jurisdiction pursuant to 28 U.S.C. § 1291.
[902]*902We review de novo a district court’s grant of summary judgment. See Warren v. City of Carlsbad, 58 F.3d 439, 441 (9th Cir.1995), cert. denied, — U.S. -, 116 S.Ct. 1261, 134 L.Ed.2d 209 (1996); Jesinger v. Nevada Fed. Credit Union, 24 F.3d 1127, 1130 (9th Cir.1994).
Free access — add to your briefcase to read the full text and ask questions with AI
OPINION
FERNANDEZ, Circuit Judge:
Leslie Abromson, Ronald Angelo, Louis Camardella, Eh Bailan, Elie de Comminges, and Sandra Kolker (collectively “Abromson”), acting on their own behalf and on behalf of a court-certified class and sub-class, appeal the district court’s judgment in favor of defendants American Pacific Corporation, Fred Gibson, Jr., C. Keith Rooker, David Keys, John R. Gibson, W. Carroll, Thomas War, Thomas Turner, Norval Pohl, and Victor Rosenzweig (collectively “AmPac”) in Abromson’s action against AmPac for securities fraud under 15 U.S.C. §§ 77k, 77o (Securities Act of 1933, as amended, §§ 11, 15) and 15 U.S.C. §§ 78j(b), 78t (Securities Exchange Act of 1934, as amended, §§ 10(b), 20) and 17 C.F.R. § 240.10b-5 (Rule 10b-5). Abromson alleged misrepresentations or omissions regarding AmPac’s relationship with Thiokol Corporation, its largest customer, and regarding the business prospects of the fire suppression agent Halotron. The district court certified a class of plaintiffs comprising any person who purchased AmPac stock between April 15, 1992 and June 11, 1993, the “class period,” and a sub-class of persons who purchased stock in AmPac’s public offering of April 15, 1992. The district court granted AmPac’s motion for summary judgment on the Thiokol claims and it granted summary judgment in favor of the outside directors of AmPac on all claims. After trial, a jury returned a verdict in favor of AmPac on the Halotron claims. The district court thereafter entered judgment for AmPac. Abromson appealed and AmPac cross appealed the district court’s denial of its motion for judgment as a matter of law on claims that went to the jury. We affirm.
BACKGROUND
On April 15, 1992, AmPac and certain selling shareholders issued shares in a public offering of its common stock. On that date, AmPac’s stock closed trading at a price of $31)4 per share. On June 11, 1993, AmPac’s stock closed trading at a price of $20)4 per share. Abromson brought suit against AmPac under §§ 77k, 77o, 78j(b), 78t, and Rule 10b-5, on the basis of alleged misstatements regarding AmPac’s relationship with Thiokol, the customer that provided the lion’s share of AmPac’s revenues (40%, 47%, and 63%, respectively, in the three years preceding 1991). Abromson alleged misrepresentations or omissions regarding AmPac’s agreement to supply Thiokol with ammonium perchlorate (AP), the oxidizing agent for solid-fuel rockets.
When an explosion destroyed one of the two AP manufacturing facilities in the United States, NASA became concerned because it wanted two sources for that substance. That led to a contract between AmPac’s subsidiary, Western Electrochemical Corporation [901]*901and Thiokol.1 AmPac agreed to build a new AP manufacturing facility and Thiokol advanced the funds with which to begin construction. AmPac also entered into a loan agreement with Security Pacific Bank Washington, N.A.,2 pursuant to which it obtained financing of $92 million for the facility. Thiokol agreed that during the seven year amortization period of the Security Pacific loan, it would place enough orders for AP to assure repayment of the loan. Moreover, Thiokol agreed to pay a surcharge on all AP orders during the amortization period of the loan in order to help defray the costs of constructing and financing the AP manufacturing facility. The agreements between Thiokol and AmPac were incorporated by reference into Thiokol’s contract with NASA.
Prior to and during the class period, AmPac made numerous declarations in which it stated that Thiokol was “obligated” to purchase AP during the seven-year period following the commencement of the agreements, that these sales were “assured,” and that the Thiokol contract would “insulate” AmPac from competition in the AP market. AmPac included those statements in its SEC filings, including AmPac’s annual 10-K reports for 1991 and 1992, as well as the prospectus for the April 15, 1992 stock offering.
At the same time, NASA wanted to shorten the seven-year amortization period for AmPac’s loan from Security Pacific, and AmPac was engaged in discussions about that with officials from NASA and Thiokol. In fact, AmPac’s 1991 10-K report indicates the possibility of paying off the Security Pacific loan in 1994, three years earlier than anticipated by the original agreement. However, the parties disagreed on the question of whether early repayment of the loan would terminate Thiokol’s obligation to purchase AP from AmPac. The parties did not reach an agreement on repayment, and they continued to disagree regarding the effect of any repayment upon Thiokol’s purchase obligations.
The public became aware of the disagreement on June 11, 1993, when Thiokol filed suit in Utah state court against AmPac and sought a judicial declaration that complete repayment of the Security Pacific loan would terminate Thiokol’s contractual obligation to purchase AP from AmPac. Thiokol alleged that AmPac had agreed to early repayment of the loan. That agreement simply did not exist, and there was no evidence that it did. Upon public disclosure of Thiokol’s lawsuit, the price of AmPae’s stock dropped precipitously. Abromson asserts that AmPac should have publicly disclosed the disagreement among it, NASA, and Thiokol regarding the contractual agreements and that the failure to do so violated the securities laws.
Abromson also faults AmPae’s disclosures with respect to Halotron, a fire suppression agent intended to replace Halón, a more widely used substance that may cause damage to the ozone layer. The district court denied AmPac’s request for summary judgment and the case went to trial on the Halo-tron claims. During his opening statement regarding them, AmPac’s attorney made reference to the absence of a Securities and Exchange Commission enforcement proceeding against the defendants. Abromson now argues that the remark was improper and that it requires reversal of the judgment. In addition, Abromson argues that the court’s failure to give one of her proposed instructions was an error requiring reversal. AmPac moved for judgment as a matter of law on the Halotron claims both at the close of Abromson’s case and at the close of all evidence. It now cross appeals the district court’s denial of those motions.
JURISDICTION AND STANDARD OF REVIEW
The district court had jurisdiction pursuant to 28 U.S.C. § 1331. We have jurisdiction pursuant to 28 U.S.C. § 1291.
[902]*902We review de novo a district court’s grant of summary judgment. See Warren v. City of Carlsbad, 58 F.3d 439, 441 (9th Cir.1995), cert. denied, — U.S. -, 116 S.Ct. 1261, 134 L.Ed.2d 209 (1996); Jesinger v. Nevada Fed. Credit Union, 24 F.3d 1127, 1130 (9th Cir.1994). We must determine whether “the evidence, viewed in a light most favorable to the nonmoving party, presents any genuine issues of material fact and whether the district court correctly applied the law.” Warren, 58 F.3d at 441; see Jesinger, 24 F.3d at 1130. Our review “is governed by the same standard used by the trial court under Federal Rule of Civil Procedure 56(c).” Jesinger, 24 F.3d at 1130. In the trial court, the party moving for summary judgment has the initial burden of “ ‘showing’-that is pointing out to the District Court-that there is an absence of evidence to support the nonmoving party’s case,” when the nonmoving party bears the burden of persuasion on the issue in question. Celotex Corp. v. Catrett, 477 U.S. 317, 325, 106 S.Ct. 2548, 2554, 91 L.Ed.2d 265 (1986). “Summary judgment may be defeated in a securities fraud derivative suit ‘only by showing a genuine issue of fact with regard to a particular statement by [the company] or its insiders.’” Hanon v. Dataproducts Corp., 976 F.2d 497, 500 (9th Cir.1992) (quoting Schneider v. Vennard (In re Apple Computer Sec. Litig.), 886 F.2d 1109, 1118 (9th Cir.1989)).
We review a district court’s formulation of civil jury instructions for an abuse of discretion. See Fikes v. Cleghorn, 47 F.3d 1011, 1013 (9th Cir.1995). The district court must formulate jury instructions so that they fairly and adequately cover the issues presented, correctly state the law, and are not misleading. See id. We consider the instructions as a whole and apply an abuse of discretion standard to determine if they are misleading or inadequate. See Masson v. New Yorker Magazine, Inc., 85 F.3d 1394, 1397 (9th Cir.1996). We will not reverse an error in instructing the jury in a civil case if it is more probably than not harmless. See Phillips v. United States Internal Revenue Serv., 73 F.3d 939, 941 (9th Cir.1996).
DISCUSSION
I. Summary Judgment on Thiokol Claim
Abromson asserts that when public disclosures were made AmPac improperly omitted information that there was a dispute with Thiokol over the issue of the effect of the prepayment of the Security Pacific loan by AmPac. She claims that the omission was material. We do not agree.
“An omitted fact is material if there is a substantial likelihood that a reasonable shareholder would consider it important____” TSC Indus., Inc. v. Northway, Inc., 426 U.S. 438, 449, 96 S.Ct. 2126, 2132, 48 L.Ed.2d 757 (1976); see Basic, Inc. v. Levinson, 485 U.S. 224, 231, 108 S.Ct. 978, 983, 99 L.Ed.2d 194 (1988). To survive a motion for summary judgment, a plaintiff must demonstrate that a failure to disclose particular information conveyed a false or misleading impression. See Hanon, 976 F.2d at 501. We have considered a failure to disclose material only when the company had certain, concrete information contradicting its optimistic or positive statements. See, e.g., Kaplan v. Rose, 49 F.3d 1363, 1371-74 (9th Cir.1994); Hanon, 976 F.2d at 503; In re Apple Computer, 886 F.2d at 1115-16. We have also held that a plaintiff cannot demonstrate a material omission on the basis of “speculative, nebulous” evidence. See Miller v. Pezzani (In re Worlds of Wonder Sec. Litig.), 35 F.3d 1407, 1418 (9th Cir.1994); see also ZVI Trading Corp. Employees’ Money Purchase Pension Plan & Trust v. Ross (In re Time Warner Sec. Litig.), 9 F.3d 259, 267 (2d Cir.1993) (a company does not have to disclose poor progress in business negotiations, even when it previously made optimistic statements about the prospects of those dealings). When assessing materiality, we consider both the magnitude of the potential loss and the likelihood that it will actually take place. See Basic, 485 U.S. at 238, 108 S.Ct. at 987. For example, a company would not have to disclose a potentially serious loss, if it faced only an infinitesimal possibility that the loss would occur.
Abromson focuses on AmPac’s failure to disclose its disagreement with Thiokol regarding the effect of an early repayment of [903]*903the Security Pacific loan. However, that disagreement could have had adverse consequences for AmPac only if it had agreed to early repayment of the Security Pacific loan or if Thiokol or NASA could have compelled early repayment. But, there was no probative evidence that AmPac either had agreed to or could be forced to pay off that loan. In fact, in the action it filed in Utah, even Thiokol did not allege that it could compel early repayment. Rather, it baldly asserted in its declaratory judgment complaint that AmPac had already agreed to an early repayment. However, no such agreement existed, and there was no evidence that it did. Thus, even if Thiokol’s dubious claim regarding the effect of a repayment on its purchase obligations were correct, AmPac could only suffer if it agreed to an early pay off of the loan and thereby foolishly risked serious financial losses. Absent that almost inconceivable act by AmPac, Thiokol’s assertion was simply irrelevant to AmPac’s representations to the securities market and no reasonable investor could have believed otherwise. In other words, any possible negative effect resulting from the information which Abromson alleges that AmPac failed to disclose regarding its contractual relationship, rights, and duties was at most speculative and uncertain. Indeed, assuming that an early termination of Thiokol’s purchase obligation might possibly have had a serious effect on AmPac, the probability that a termination would take place without action by AmPac to fully protect its position was virtually zero. Therefore, any potential loss was immaterial under the securities laws.3
II. Halotron Claim
In his opening statement to the jury, counsel for AmPac stated that the SEC had not proceeded against AmPac. There was an immediate objection, which was sustained. Abromson now asserts that the very mention of that matter was sufficient to constitute reversible error.
We have not previously decided whether a reference during the trial of a private securities action to the absence of a SEC enforcement proceeding constitutes error at all. We do not reach that question today because it is clear that the reference was harmless. “[W]hen an appellate court ponders the probable effect of an error on a civil trial, it need only find that the jury’s verdict is more probably than not untainted by the error.” Haddad n Lockheed Calif. Corp., 720 F.2d 1454, 1459 (9th Cir.1983). Moreover, we have refused to find reversible error where concededly improper remarks were made, but not repeated, during opening statements or closing arguments. See, e.g., Kehr v. Smith Barney, Harris Upham & Co., Inc., 736 F.2d 1283, 1286 (9th Cir.1984); United States v. Vargas-Rios, 607 F.2d 831, 838 (9th Cir.1979); Moore v. Telfon Communications Corp., 589 F.2d 959, 966 (9th Cir. 1978); United States v. Hood, 493 F.2d 677, 681-82 (9th Cir.1974). The trial of the Halo-tron claim lasted eighteen days. The allegedly improper reference to the SEC that Abromson complains of occurred in AmPac’s opening statement, and the district court instructed the jury that it should only rely on the evidence in the case. It also stated that there would be no evidence on the subject of the absence of an SEC proceeding. The reference was not repeated, and it is highly improbable that it had any effect on the verdict. Thus it was harmless.
Abromson complains of the district court’s failure to give her requested jury instruction on the specific legal standard regarding misleading projections and statements of belief and optimism. However, she has waived any objection. When the district court indicated that the proposed instruction was argumentative and proposed a different one that covered the matter, she did not object, even [904]*904though it cannot be said that an objection would have been futile. Instead, Abromson acquiesced in the court’s substitute instruction. The court said, “Take a look at this one,” and her attorney said, “That’s acceptable from our perspective, your honor.” By agreeing with the court, rather than preserving an objection to the court’s denial of the proposed jury instruction, Abromson waived her right to appeal that issue. See Fed. R.Civ.P. 51 (“No party may assign as error the giving or the failure to give an instruction unless that party objects thereto before the jury retires to consider its verdict, stating distinctly the matter objected to and the grounds of the objection.”); see also Hammer v. Gross, 932 F.2d 842, 847 (9th Cir.1991) (en banc) (Canby, J., plurality opinion); Lifshitz v. Walter Drake & Sons, Inc., 806 F.2d 1426, 1430 (9th Cir.1986). In light of her acquiescence in the court’s ruling, it can hardly be said that Abromson “stated distinctly” the matter objected to and the ground of the objection.4
III. Cross-Appeal
Our decision to affirm the district court’s final judgment renders AmPae’s cross-appeal moot. We therefore dismiss it. See Kapp v. National Football League, 586 F.2d 644, 649-50 (9th Cir.1978).
The judgment of the district court is AFFIRMED. AmPac’s cross-appeal is DISMISSED.